Dashboard
Manage Tickers

SLXN


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
Silexion Therapeutics Says SIL204 Demonstr...
09/30/2025 12:41:41

New data in human cancer cell lines provides confirmation of pan-KRAS mutation inhibition with inhibition of G12D, G12V, G12R, ...

Core News & Articles
Silexion Therapeutics Files For Mixed Shel...
09/26/2025 20:34:02

- SEC Filing

Core News & Articles
Silexion Therapeutics Regains Nasdaq Compl...
09/25/2025 12:46:37

Core News & Articles
12 Health Care Stocks Moving In Friday's I...
09/12/2025 17:06:17

silexion-therapeutics-shares-surge-on-positive-preclinical-pancreatic-cancer-data
Silexion Therapeutics Shares Surge On Posi...
09/11/2025 17:26:25

Silexion's SIL204 showed strong anti-tumor effects in preclinical tests, reaching major metastasis sites in pancreatic canc...

Core News & Articles
Silexion Therapeutics Prices $6M Public Of...
09/11/2025 13:18:12

Silexion Therapeutics Corp. (NASDAQ:SLXN) ("Silexion Therapeutics" or the "Company"), a clinical-stage biotech ...

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
09/11/2025 12:10:10

Core News & Articles
Market-Moving News for September 11th
09/11/2025 11:26:37

SLXN: 50% | Silexion Highlights Preclinical Data Of SIL204 Supporting Dual-Route Treatment Strategy With Phase 2/3 Trial On Tra...

Core News & Articles
Silexion Highlights Preclinical Data Of SI...
09/11/2025 11:07:35

New Positive Preclinical Data Shows Succesful Drug Distribution to Liver, Peritoneum, and Lung with Measurable Reductions in Tu...

Core News & Articles
Silexion's SIL204 Reaches All Major Sites ...
09/11/2025 11:01:56

Silexion Therapeutics Corp. (NASDAQ:SLXN), a clinical-stage biotechnology company pioneering RNA interference (RNAi) therapies ...

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
09/09/2025 17:06:26

Core News & Articles
Silexion Therapeutics Selects A Contract R...
09/04/2025 13:28:42

Strategic CRO to Support Path to Phase 2/3 Trials Following Recently Demonstrated Groundbreaking 97% Inhibition Rates for SIL20...

Core News & Articles
CORRECTION: Silexion Therapeutics Q2 EPS $...
08/12/2025 21:59:53

Silexion Therapeutics (NASDAQ:SLXN) reported quarterly losses of $(4.32) per share which missed the analyst consensus estimate ...

Core News & Articles
12 Health Care Stocks Moving In Monday's P...
08/11/2025 12:08:21

crude-oil-down-2-amazon-shares-tumble-after-q2-results
Crude Oil Down 2%; Amazon Shares Tumble Af...
08/01/2025 17:44:51

Core News & Articles
12 Health Care Stocks Moving In Friday's I...
08/01/2025 17:07:08

nasdaq-dips-over-2-apple-earnings-top-views
Nasdaq Dips Over 2%; Apple Earnings Top Views
08/01/2025 14:19:23

Core News & Articles
Reported Earlier, Silexion Therapeutics An...
08/01/2025 07:16:47

In consideration for the immediate exercise of the warrants for cash, the Company will issue new unregistered warrants to purch...

why-is-silexion-therapeutics-stock-trading-higher-on-thursday
Why Is Silexion Therapeutics Stock Trading...
07/31/2025 19:14:14

Silexion's SIL204 showed strong KRAS-targeted inhibition across pancreatic, colorectal, and lung cancer cells, supporting i...

Core News & Articles
Silexion Therapeutics Shares Resume Trade ...
07/31/2025 14:23:31

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION